Hesperadin suppresses pancreatic cancer through ATF4/GADD45A axis at nanomolar concentrations
Yixuan Zhang(Nanjing Drum Tower Hospital), Shu Zhang(Nanjing Drum Tower Hospital), Xiaoping Zou(Nanjing Drum Tower Hospital), Qisi Zheng(Nanjing Drum Tower Hospital), Jing Zhao(Jiangxi Science and Technology Normal University), Haochen Su(Nanjing Drum Tower Hospital), Shanshan Shen(Xian Center for Disease Control and Prevention), Yao Fu(Illumina (United States)), Ying Lv(Nanjing Drum Tower Hospital), Jianzhuang Wu(Nanjing Drum Tower Hospital), Kun Wang(Xuzhou Medical College), Lei Wang(University of Electronic Science and Technology of China), Guifang Xu(Jiangsu University), Ranran Yu(China Pharmaceutical University), Chao Yan(Harbin Institute of Technology), Siqi Zhou(Jiangsu University), Hao Wu(Nanjing Drum Tower Hospital)
Cited by 30
Related Papers
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma
|New England Journal of Medicine|2023|530
Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma.
|PubMed|1994|485
Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva
|Gynecologic Oncology|1990|430
Exogenous lipids promote the growth of breast cancer cells via CD36
|Oncology Reports|2017|197